Principle Investigator: Prof. Qiang Feng, PhD
A healthy intestinal microbiome is the prerequisite for our health. Dysfunctions of the intestinal microbiome caused by modern lifestyle including western diet, medications and physical inactivity are suspected to cause numerous metabolic, immunological and oncological diseases.
The Microbiomics research group focuses on the investigation of the impact of a dysfunctional microbiome in the context of chronic inflammatory and metabolic diseases. Also we study the basics of targeted and dietary modulation of the microbiome in order to specifically prevent and treat chronic diseases such as metabolic syndrome, inflammatory bowel disease and colorectal cancer.
Our core technology is the bioinformatic analysis of complex and multidimensional data including metagenomics and metabolomics data.
Feng Qiang, PhD, is Professor of Microbiome Research at School of Stomatology, Shandong University. He is highly engaged in the research of human microbiome and its pathogenic mechanism on human diseases. He has published over 60 SCI papers, including Nature Biotechnology, Nature Medicine, Nature Communications and Gut. He was awarded as the 2020 Clarivate global high Cited Scientist . He applied and authorized 125 patents, which ranks 14th of the inventor all over the world and 1st within China. He awarded the titles of Top Young Talents Program of China, Young Experts of Taishan Scholars in Shandong Province, Outstanding Young Scholars of Shandong University, Young Scholars of Qilu in Shandong University, Leading Scientist of Jinan City, Innovation Pioneer of Jinan City.
Master's and PhD theses can be offered from the summer semester 2021.
Contact: Prof. Qiang Feng, PhD or Prof. Christian Sina
Prof. Qiang Feng